Risk factors
Invivyd (IVVD) risk factors
Item 1A of every Invivyd, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors104 risks22 new9 dropped21 reworded
Invivyd added new risks regarding its Silicon Valley Bank loan agreement and cash runway of $226.7 million as of year-end 2025. The company updated figures for its federal and state net operating loss carryforwards and detailed ongoing management transitions.
Filed Mar 05, 2026 - FY2024 10-K risk factors91 risks
Invivyd faces going concern doubts, relying heavily on PEMGARDA's commercial success for revenue and profitability. The company has incurred substantial net losses, reaching $169.9 million in 2024. Operations are heavily dependent on third-party manufacturers like WuXi Biologics and compliance with FDA regulations.
Filed Mar 20, 2025